Opus Genetics, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Opus Genetics, Inc. (IRD) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$154.85 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-03-07
- Opus Genetics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was $4.15M, a 517.06% increase year-over-year.
- Opus Genetics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$502.55K.
- Opus Genetics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was -$1.20M.
- Opus Genetics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was -$2.60M.
- Opus Genetics, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$154.85K.
- Opus Genetics, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$2.68M, a 294.29% decline from fiscal 2016.
- Opus Genetics, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $1.38M, a 269.52% increase from fiscal 2015.
- Opus Genetics, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $373.19K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 132 month | Cash and Cash Equivalents, Period Increase (Decrease) 135 month | Cash and Cash Equivalents, Period Increase (Decrease) 138 month | Cash and Cash Equivalents, Period Increase (Decrease) 141 month | Cash and Cash Equivalents, Period Increase (Decrease) 144 month | Cash and Cash Equivalents, Period Increase (Decrease) 147 month | Cash and Cash Equivalents, Period Increase (Decrease) 150 month | Cash and Cash Equivalents, Period Increase (Decrease) 153 month | Cash and Cash Equivalents, Period Increase (Decrease) 156 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | $4.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $3.65M derived: sum of 2 quarters · filed 2019-03-07 | $2.45M derived: sum of 3 quarters · filed 2019-03-07 | -$154.85K 10-K · filed 2019-03-07 | |||||||||
| 2018-09-30 | -$502.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | -$1.71M derived: sum of 2 quarters · filed 2018-11-02 | -$4.31M 10-Q · filed 2018-11-02 | -$3.63M derived: sum of 4 quarters · filed 2019-03-07 | |||||||||
| 2018-06-30 | -$1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | -$3.80M 10-Q · filed 2018-08-03 | -$3.13M derived: sum of 3 quarters · filed 2019-03-07 | -$3.70M derived: sum of 4 quarters · filed 2019-03-07 | |||||||||
| 2018-03-31 | -$2.60M 10-Q · filed 2018-05-04 | -$1.93M derived: sum of 2 quarters · filed 2019-03-07 | -$2.49M derived: sum of 3 quarters · filed 2019-03-07 | -$4.19M derived: sum of 4 quarters · filed 2019-03-07 | |||||||||
| 2017-12-31 | $672.97K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $108.64K derived: sum of 2 quarters · filed 2019-03-07 | -$1.59M derived: sum of 3 quarters · filed 2019-03-07 | -$2.68M 10-K · filed 2019-03-07 | |||||||||
| 2017-09-30 | -$564.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | -$2.26M derived: sum of 2 quarters · filed 2018-11-02 | -$3.35M 10-Q · filed 2018-11-02 | -$166.05K derived: sum of 4 quarters · filed 2018-11-02 | |||||||||
| 2017-06-30 | -$1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | -$2.79M 10-Q · filed 2018-08-03 | $398.28K derived: sum of 3 quarters · filed 2018-08-03 | $912.52K derived: sum of 4 quarters · filed 2018-08-03 | |||||||||
| 2017-03-31 | -$1.09M 10-Q · filed 2018-05-04 | $2.09M derived: sum of 2 quarters · filed 2018-05-04 | $2.61M derived: sum of 3 quarters · filed 2018-05-04 | $22.52K derived: sum of 4 quarters · filed 2018-05-04 | |||||||||
| 2016-12-31 | $3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $3.70M derived: sum of 2 quarters · filed 2018-03-09 | $1.11M derived: sum of 3 quarters · filed 2018-03-09 | $1.38M 10-K · filed 2018-03-09 | |||||||||
| 2016-09-30 | $514.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | -$2.07M derived: sum of 2 quarters · filed 2017-11-03 | -$1.81M 10-Q · filed 2017-11-03 | -$4.06M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||
| 2016-06-30 | -$2.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | -$2.32M 10-Q · filed 2017-08-04 | -$4.57M derived: sum of 3 quarters · filed 2018-03-09 | -$2.09M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||
| 2016-03-31 | $264.21K 10-Q · filed 2017-05-03 | -$1.99M derived: sum of 2 quarters · filed 2018-03-09 | $493.01K derived: sum of 3 quarters · filed 2018-03-09 | -$265.56K derived: sum of 4 quarters · filed 2018-03-09 | |||||||||
| 2015-12-31 | -$2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $228.79K derived: sum of 2 quarters · filed 2018-03-09 | -$529.77K derived: sum of 3 quarters · filed 2018-03-09 | $373.19K 10-K · filed 2018-03-09 | |||||||||
| 2015-09-30 | $2.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $1.72M derived: sum of 2 quarters · filed 2016-11-04 | $2.62M 10-Q · filed 2016-11-04 | -$2.52M derived: sum of 4 quarters · filed 2017-02-24 | |||||||||
| 2015-06-30 | -$758.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $144.40K 10-Q · filed 2016-08-05 | -$5.00M derived: sum of 3 quarters · filed 2017-02-24 | -$28.13M derived: sum of 4 quarters · filed 2017-02-24 | |||||||||
| 2015-03-31 | $902.97K 10-Q · filed 2016-05-06 | -$4.24M derived: sum of 2 quarters · filed 2017-02-24 | -$27.38M derived: sum of 3 quarters · filed 2017-02-24 | -$29.34M derived: sum of 4 quarters · filed 2017-02-24 | |||||||||
| 2014-12-31 | -$5.15M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | -$28.28M derived: sum of 2 quarters · filed 2017-02-24 | -$30.25M derived: sum of 3 quarters · filed 2017-02-24 | -$8.86M 10-K · filed 2017-02-24 | |||||||||
| 2014-09-30 | -$23.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | -$25.10M derived: sum of 2 quarters · filed 2015-11-02 | -$3.72M 10-Q · filed 2015-11-02 | $100.66K derived: sum of 4 quarters · filed 2016-03-14 | |||||||||
| 2014-06-30 | -$1.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $19.42M 10-Q · filed 2015-08-07 | $23.23M derived: sum of 3 quarters · filed 2016-03-14 | $28.13M derived: sum of 4 quarters · filed 2016-03-14 | |||||||||
| 2014-03-31 | $21.38M 10-Q · filed 2015-05-08 | $25.20M derived: sum of 2 quarters · filed 2016-03-14 | $30.09M derived: sum of 3 quarters · filed 2016-03-14 | $28.00M derived: sum of 4 quarters · filed 2016-03-14 | $40.07M 10-Q · filed 2014-05-14 | ||||||||
| 2013-12-31 | $3.82M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $8.71M derived: sum of 2 quarters · filed 2016-03-14 | $6.62M derived: sum of 3 quarters · filed 2016-03-14 | $5.20M 10-K · filed 2016-03-14 | $18.69M 10-K · filed 2014-03-21 | ||||||||
| 2013-09-30 | $4.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $2.80M derived: sum of 2 quarters · filed 2014-11-12 | $1.38M 10-Q · filed 2014-11-12 | $7.49M derived: sum of 4 quarters · filed 2014-11-12 | $14.87M 10-Q · filed 2013-11-13 | ||||||||
| 2013-06-30 | -$2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | -$3.51M 10-Q · filed 2014-08-13 | $2.60M derived: sum of 3 quarters · filed 2014-08-13 | $1.50M derived: sum of 4 quarters · filed 2014-08-13 | $9.98M 10-Q · filed 2013-08-12 | ||||||||
| 2013-03-31 | -$1.42M 10-Q · filed 2014-05-14 | $4.69M derived: sum of 2 quarters · filed 2014-05-14 | $3.59M derived: sum of 3 quarters · filed 2014-05-14 | $3.97M derived: sum of 4 quarters · filed 2014-05-14 | $12.07M 10-Q · filed 2013-05-09 | ||||||||
| 2012-12-31 | $6.11M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $5.00M derived: sum of 2 quarters · filed 2014-03-21 | $5.39M derived: sum of 3 quarters · filed 2014-03-21 | $3.63M 10-K · filed 2014-03-21 | $13.49M 10-K · filed 2013-03-22 | ||||||||
| 2012-09-30 | -$1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$721.11K derived: sum of 2 quarters · filed 2013-11-13 | -$2.48M 10-Q · filed 2013-11-13 | -$5.84M derived: sum of 4 quarters · filed 2013-11-13 | $7.38M 10-Q · filed 2012-11-08 | ||||||||
| 2012-06-30 | $381.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | -$1.38M 10-Q · filed 2013-08-12 | -$4.73M derived: sum of 3 quarters · filed 2013-08-12 | -$7.64M derived: sum of 4 quarters · filed 2013-08-12 | $8.48M 10-Q · filed 2012-08-08 | ||||||||
| 2012-03-31 | -$1.76M 10-Q · filed 2013-05-09 | -$5.12M derived: sum of 2 quarters · filed 2013-05-09 | -$8.03M derived: sum of 3 quarters · filed 2013-05-09 | -$12.41M derived: sum of 4 quarters · filed 2013-05-09 | $8.10M 10-Q · filed 2012-05-09 | ||||||||
| 2011-12-31 | -$3.36M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | -$6.27M derived: sum of 2 quarters · filed 2013-03-22 | -$10.65M derived: sum of 3 quarters · filed 2013-03-22 | -$2.48M 10-K · filed 2013-03-22 | |||||||||
| 2011-09-30 | -$2.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$7.30M derived: sum of 2 quarters · filed 2012-11-08 | $876.69K 10-Q · filed 2012-11-08 | -$2.61M derived: sum of 4 quarters · filed 2012-11-08 | |||||||||
| 2011-06-30 | -$4.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $3.79M 10-Q · filed 2012-08-08 | $297.93K derived: sum of 3 quarters · filed 2012-08-08 | -$1.69M derived: sum of 4 quarters · filed 2012-08-08 | |||||||||
| 2011-03-31 | $8.17M 10-Q · filed 2012-05-09 | $4.68M derived: sum of 2 quarters · filed 2012-05-09 | $2.70M derived: sum of 3 quarters · filed 2012-05-09 | ||||||||||
| 2010-12-31 | -$3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16 | -$5.47M derived: sum of 2 quarters · filed 2012-03-16 | $5.04M 10-K · filed 2012-03-16 | ||||||||||
| 2010-09-30 | -$1.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $8.53M 10-Q · filed 2011-11-09 | |||||||||||
| 2010-06-30 | $10.52M 10-Q · filed 2011-08-09 | ||||||||||||
| 2009-12-31 | $6.93M 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |